Hedge Funds Hated These Healthcare Stocks in Q1
The healthcare sector is down by about 3.75% so far this year, after enjoying a lengthy bull run into the middle of 2015.
Pacira Biosciences Inc. (PCRX)
Market is closed
News
- First
- << Previous
- 41 - 50
- Next >>
Why Are These Five Stocks Surging on Tuesday?
Seeing as all three indexes have surged more than 1% in morning trading as the Federal Reserve promises interest rates will still be low for a while, shares of Inland Real Estate Corporation (NYSE:IRC...
Should You Buy Pacira Pharmaceuticals Inc (PCRX)?
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not...
A Look at 5 Major Stock Market Gainers and the Drivers Behind Their Sharp Uptrend
As stock markets are trading in a narrow range with a slight negative bias today, five stocks are showing significant upside price movement backed by high volumes.
Four Hot Biotechs Among The Day’s Big Winners
On a day when Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is deep in the red following the release of its third quarter earnings, four other biotech stocks are making strong gains.
Goldman Sachs And Hedge Funds See Big Things For These Small-caps
The recent pull back in the Russell 2000 index left it down about 10% on a year-to-date basis just before the start of this month.
What Hedge Funds Think Of Goldman Sachs' Top Healthcare Takeover Targets
A surge of M&A activity involving healthcare, financial, and retail companies boosted the value of deals in July to over $430 billion, resulting in the seventh-busiest month on record in terms of value...
Baker Bros. Advisors Buys More DBV Technologies S.A. (DBVT); Visium Asset Management Goes Long On Pacira Pharmaceuticals Inc. (PCRX)
According to a freshly-amended 13G filing with the SEC, Baker Bros. Advisors LP, founded by Julian Baker and Felix Baker, revealed it owns 15.1% of DBV Technologies S.A.
Is Pacira Pharmaceuticals Inc (PCRX) Going to Burn These Hedge Funds?
To the average investor, there are many methods market participants can use to analyze publicly traded companies. Some of the most under-the-radar are hedge fund and insider trading activity.
This Metric Says You Are Smart to Buy Neurocrine Biosciences, Inc. (NBIX)
In the financial world, there are dozens of indicators investors can use to track publicly traded companies. Two of the best are hedge fund and insider trading movement.
- First
- << Previous
- 41 - 50
- Next >>
Billionaire Hedge Funds
